Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
58,810,431
-
Share change
-
-2,789,634
-
Total reported value
-
$595,736,469
-
Put/Call ratio
-
113%
-
Price per share
-
$10.13
-
Number of holders
-
222
-
Value change
-
-$24,830,057
-
Number of buys
-
82
-
Number of sells
-
108
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2023
As of 31 Dec 2023,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,810,431 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Deep Track Capital, LP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Pictet Asset Management Holding SA, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, and MORGAN STANLEY.
This page lists
222
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.